Stockscreener 앱 받기
11.98
12.11%
-1.65
시간 외 거래:
12.04
0.06
+0.50%
전일 마감가:
$13.63
열려 있는:
$13.57
하루 거래량:
5.28M
Relative Volume:
4.80
시가총액:
$882.50M
수익:
$193.35M
순이익/손실:
$-177.58M
주가수익비율:
-4.8898
EPS:
-2.45
순현금흐름:
$-172.43M
1주 성능:
-10.33%
1개월 성능:
-34.86%
6개월 성능:
-35.70%
1년 성능:
-51.08%
1일 변동 폭
$11.79
$13.74
1주일 범위
$11.79
$13.94
52주 변동 폭
$11.79
$28.47
슈뢰딩거 Stock (SDGR) Company Profile
명칭
Schrodinger Inc
전화
503-299-1150
주소
1540 BROADWAY, NEW YORK, NY
Compare SDGR vs VEEV, TEM, BTSG, HQY, DOCS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
11.98 | 1.00B | 193.35M | -177.58M | -172.43M | -2.45 |
|
VEEV
Veeva Systems Inc
|
177.04 | 30.74B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
53.61 | 9.94B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
40.06 | 7.10B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
76.92 | 6.69B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
25.96 | 5.03B | 550.17M | 201.35M | 232.07M | 1.00 |
슈뢰딩거 Stock (SDGR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-15 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-09-30 | 개시 | Goldman | Neutral |
| 2025-08-15 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-08-14 | 개시 | Barclays | Overweight |
| 2025-07-03 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-07-02 | 개시 | Leerink Partners | Outperform |
| 2023-12-05 | 개시 | KeyBanc Capital Markets | Overweight |
| 2023-05-05 | 재개 | Piper Sandler | Overweight |
| 2022-12-19 | 개시 | Goldman | Neutral |
| 2022-03-01 | 개시 | Citigroup | Buy |
| 2021-11-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-19 | 개시 | Piper Sandler | Overweight |
| 2021-11-11 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-10-13 | 개시 | Berenberg | Buy |
| 2021-09-01 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-25 | 개시 | Craig Hallum | Buy |
| 2020-11-23 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-10-12 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-03-02 | 개시 | BMO Capital Markets | Outperform |
| 2020-03-02 | 개시 | Jefferies | Hold |
| 2020-03-02 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
슈뢰딩거 주식(SDGR)의 최신 뉴스
Schrodinger (NASDAQ:SDGR) Insider Sells $16,617.30 in Stock - MarketBeat
Schrodinger (NASDAQ:SDGR) Reaches New 12-Month LowWhat's Next? - MarketBeat
Schrödinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25 - PharmiWeb.com
Schrodinger stock hits 52-week low at 12.8 USD - Investing.com
Schrodinger stock hits 52-week low at 12.8 USD By Investing.com - Investing.com India
Schrodinger, Inc. (NASDAQ:SDGR) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Trading Systems Reacting to (SDGR) Volatility - Stock Traders Daily
With A 26% Price Drop For Schrödinger, Inc. (NASDAQ:SDGR) You'll Still Get What You Pay For - simplywall.st
Schrodinger stock hits 52-week low at 13.43 USD By Investing.com - Investing.com Nigeria
Schrodinger (NASDAQ:SDGR) Hits New 12-Month LowShould You Sell? - MarketBeat
Schrodinger stock hits 52-week low at 13.43 USD - Investing.com
Schrodinger, Inc. (SDGR) Investor Outlook: Unveiling a 77.43% Potential Upside Amidst Innovative Drug Discovery and Software Growth - DirectorsTalk Interviews
TruBridge (TBRG) Surges 5.6%: Is This an Indication of Further Gains? - Nasdaq
Analysts Are Bullish on Top Healthcare Stocks: Spectral AI (MDAI), Schrodinger (SDGR) - The Globe and Mail
Schrodinger (NASDAQ:SDGR) Upgraded at Wall Street Zen - MarketBeat
Is Schrödinger Inc. stock a good dividend stock2025 Historical Comparison & Weekly Stock Performance Updates - mfd.ru
Schrodinger, Inc. (SDGR) Investor Outlook: Unveiling a 60.98% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Schrodinger Inc stock hits 52-week low at $15.97 By Investing.com - Investing.com Nigeria
Schrodinger Inc stock hits 52-week low at $15.97 - Investing.com
How Schrodinger Inc. (SDGR) Affects Rotational Strategy Timing - Stock Traders Daily
Massachusetts Financial Services Co. MA Acquires 577,899 Shares of Schrodinger, Inc. $SDGR - MarketBeat
86,319 Shares in Schrodinger, Inc. $SDGR Acquired by Campbell & CO Investment Adviser LLC - MarketBeat
Stephens Investment Management Group LLC Trims Stock Holdings in Schrodinger, Inc. $SDGR - MarketBeat
Schrodinger (NASDAQ:SDGR) Shares Down 5.2%Time to Sell? - MarketBeat
Sumitomo Mitsui Trust Group Inc. Has $91.37 Million Stock Holdings in Schrodinger, Inc. $SDGR - MarketBeat
(SDGR) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Why Schrödinger Inc. stock could be next big winnerMarket Performance Report & Low Risk Entry Point Guides - Bộ Nội Vụ
Schrodinger stock rating reiterated at Buy by TD Cowen on strategic priorities By Investing.com - Investing.com South Africa
Assessing Schrödinger (SDGR) Valuation After Recent Uneven Share Price Momentum - Yahoo Finance
Schrödinger partners with Lilly TuneLab on AI drug discovery - Drug Target Review
Schrodinger stock rating reiterated at Buy by TD Cowen on strategic priorities - Investing.com Australia
Schrödinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities - BioSpace
Schrödinger outlines 2026 priorities after strong 2025 By Investing.com - Investing.com Nigeria
Schrödinger outlines 2026 priorities after strong 2025 - Investing.com
Manas AI Secures Strategic Advantage through Unique Deep Integration with Schrödinger’s Physics + AI Discovery Platform - 01net
Schrodinger, Inc. (NASDAQ:SDGR) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Chemoinformatics Market to Reach US$ 24.43 Billion by 2033 | CAGR - openPR.com
Schrodinger to offer Eli Lilly’s AI drug discovery platform on its software - WKZO
Will Schrödinger Inc. stock benefit from automation2025 Performance Recap & Capital Efficiency Focused Ideas - Улправда
Schrodinger (NASDAQ:SDGR) Rating Lowered to Sell at Wall Street Zen - MarketBeat
Schrödinger partners with Lilly TuneLab to enhance drug discovery By Investing.com - Investing.com Nigeria
Schrödinger, Inc.'s (NASDAQ:SDGR) Earnings Haven't Escaped The Attention Of Investors - 富途牛牛
Is Schrödinger’s TuneLab AI Integration Reshaping the Investment Case For SDGR? - simplywall.st
Schrödinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign - pharmiweb.com
Schrödinger (SDGR) Partners with Eli Lilly for AI-Driven Drug Di - GuruFocus
Schrodinger to offer Eli Lilly's AI drug discovery platform on its software - Reuters
Eli Lilly in pact with Schrödinger, Revvity for AI-driven drug discovery - MSN
Schrödinger (SDGR) Partners with Eli Lilly for AI Drug Discovery - GuruFocus
Eli Lilly in pact with Schrödinger in AI-related drug discovery - Seeking Alpha
슈뢰딩거 (SDGR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.28%
0.00%
자본화:
|
볼륨(24시간):